Oscar Health (NYSE:OSCR) Stock Price Down 5.7% – What’s Next?

Oscar Health, Inc. (NYSE:OSCR)’s stock price was down 5.7% during mid-day trading on Tuesday . The stock traded as low as $17.03 and last traded at $17.05. Approximately 647,633 shares traded hands during trading, a decline of 80% from the average daily volume of 3,208,691 shares. The stock had previously closed at $18.09.

Analyst Ratings Changes

A number of research firms recently weighed in on OSCR. Piper Sandler reaffirmed an “overweight” rating and set a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. Bank of America downgraded shares of Oscar Health from a “neutral” rating to an “underperform” rating and lowered their price target for the stock from $21.00 to $13.50 in a research note on Wednesday. Finally, UBS Group assumed coverage on shares of Oscar Health in a report on Monday, October 7th. They set a “neutral” rating and a $23.00 target price for the company. One analyst has rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $22.93.

Oscar Health Stock Performance

The business’s fifty day moving average price is $18.75 and its 200-day moving average price is $18.45. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.91. The stock has a market cap of $3.76 billion, a PE ratio of -119.54, a P/E/G ratio of 35.84 and a beta of 1.67.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.16 by $0.04. The firm had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.13 billion. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. Oscar Health’s revenue was up 44.6% on a year-over-year basis. During the same period in the prior year, the business posted ($0.07) EPS. As a group, equities research analysts forecast that Oscar Health, Inc. will post 0.01 EPS for the current fiscal year.

Insider Buying and Selling at Oscar Health

In related news, insider Mario Schlosser sold 3,198 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the completion of the transaction, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, insider Mario Schlosser sold 3,198 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the sale, the insider now directly owns 76,982 shares of the company’s stock, valued at $1,384,906.18. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Victoria Baltrus sold 4,226 shares of the business’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $76,025.74. Following the completion of the sale, the chief accounting officer now owns 140,648 shares in the company, valued at $2,530,257.52. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 169,569 shares of company stock valued at $3,007,069 over the last 90 days. 25.11% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Oscar Health

Several large investors have recently modified their holdings of OSCR. Avalon Trust Co bought a new stake in shares of Oscar Health during the 1st quarter worth approximately $69,000. Point72 Hong Kong Ltd purchased a new stake in Oscar Health in the second quarter worth $78,000. Quest Partners LLC purchased a new stake in Oscar Health in the second quarter worth $93,000. KBC Group NV lifted its position in shares of Oscar Health by 41.2% during the third quarter. KBC Group NV now owns 4,552 shares of the company’s stock worth $97,000 after purchasing an additional 1,328 shares during the last quarter. Finally, Amalgamated Bank boosted its stake in shares of Oscar Health by 27.7% during the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock valued at $106,000 after purchasing an additional 1,458 shares during the period. Institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.